10. April 2018
Making Pharmaceuticals is covering the hot topics in the pharmaceutical industry from continuous manufacturing, supply chain, serialization, data integrity, regulatory, Brexit and many more in a 2 day conference and exhibition. Pharmaceutical excipient topics are covered in different sessions with the following presentations: Expanded Design Space in Hot Melt Extrusion with High Productivity Hypromellose Acetate Succinate Phospholipids as Business Opportunities for Pharmaceutical Line Extension...
22. November 2017
Regulators require excipient users to qualify their suppliers based on GMP/GDP audits and they have indicated that third party auditing of suppliers is acceptable if a creditable certification body issues certificates and audit reports by employing qualified auditors who are demonstrably credible in suitable GMP/GDP standards and in the needs of the pharmaceutical industry
24. August 2017
We now offer EXCiPACT compliant high quality MCC from our partner Chemfield Cellulose.
31. May 2017
EXCiPACT asbl is delighted to announce that the Ashland Speciality Ingredients site in Doel, Belgium has recently been awarded an EXCiPACT GMP Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies. The Certificate demonstrates that the Ashland Speciality Ingredients (ASI) site in Doel, Belgium, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers the production of...
24. May 2017
EXCiPACT asbl is delighted to announce that the Sigachi Industries Pvt. Ltd.’s site in Dahej, India has recently been awarded an EXCiPACT GMP Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.
07. April 2017
Brussels, 6 April 2017 EXCiPACT asbl is pleased to announce their very first Japanese certification. The Croda Japan K.K. Shiga factory has just been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies. The Certificate demonstrates that the Croda Japan Shiga factory in Shiga-Ken, Japan manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacture of...
25. March 2017
Chemische Fabrik Budenheim site receives EXCiPACT GMP Certification as pharmaceutical excipient suppliers Speciality products and phosphates company, Budenheim, has received an GMP/GDP Certificate for pharmaceutical excipients produced at its Chemische Fabrik site in Germany. The certificate demonstrates that the site manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) Certification Standards. Its scope covers...
21. March 2017
Brussels, 21 March 2017 - News Release EXCiPACT EXCiPACT asbl is delighted to announce that the Sudeep Pharma Private Ltd’s Vadodara site in India has recently been awarded an EXCiPACT GMP Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies. The Certificate demonstrates that the Sudeep Pharma Pvt. Ltd. site in Vadodara, Gujarat, India, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification...
15. March 2017
Brussels, 14 March 2017 EXCiPACT asbl is delighted to announce that the Carbagas Domdidier site has recently been awarded an EXCiPACT Certificate from AJA, one of EXCIPACT’s internationally-recognised Certification Bodies. The Certificate demonstrates that the Carbagas site in Domdidier, Switzerland, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard. Its scope covers manufacturing (filling) of pharmaceutical grade gases...
09. March 2017
The EXCiPACT Board commissioned a project team to undertake a revision of the EXCiPACT standards to align them to ISO 9001:2015 and ISO/IEC 17021-1:2015 without change or enhancement of any individual requirements, other than to correct for errors in the original publication. The draft revision has been completed and is now available for public comment via a Review Template, mandatory for the submission of comments. Links to both documents are: 2017 EXCiPACT Draft Revised Standards 2017...